Literature DB >> 6095990

Cytogenetics of small cell carcinoma of the lung.

D H Wurster-Hill, L A Cannizzaro, O S Pettengill, G D Sorenson, C C Cate, L H Maurer.   

Abstract

Nineteen cell lines derived from various malignant tissues of 15 patients with small cell carcinoma of the lung (SCCL) have been studied. The results showed heterogeneity in all cell lines, with no one consistent abnormality among them. Cell lines from 11 of the patients had minute and double minute chromosomes, and cell lines from 2 patients had abnormally banding regions, designated as ABRs, as distinguished from homogeneously staining regions (HSRs). The latter 2 and several of the former cell lines were derived from specimens taken before the patients were placed on therapy. All but 2 of the cell lines had a constant marker load, consisting of 24%-35% of the complement. Some markers remained stable through months and years of culture life, while other markers came and went. Chromosomes #1, #6 and #11 were most frequently involved in marker formation in the cell lines, and these were compared to similar markers in direct bone marrow preparations. Chromosome #1 markers were of variable structure, whereas #6 and #11 most often took the form of 6q- and 11p+ markers, with breakpoints most frequently at 6q23-25 and 11p11-12. A 3p- marker was found in a minority of cell lines. All of these markers were also found in direct marrow preparations from some patients with SCCL. Nonmonoclonal tumors arose from inoculation of bimodal cell lines into nude mice, but population selection by undetermined mechanism was evident. Cytogenetic parameters showed no positive correlation with hormone production by these cell lines.

Entities:  

Mesh:

Year:  1984        PMID: 6095990     DOI: 10.1016/0165-4608(84)90075-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

1.  Localization of the human HF.10 finger gene on a chromosome region (3p21-22) frequently deleted in human cancers.

Authors:  E Donti; L Lanfrancone; K Huebner; A Pascucci; G Venti; G Pengue; F Grignani; C M Croce; L Lania; P G Pelicci
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

2.  Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumors.

Authors:  B E Johnson; A Y Sakaguchi; A F Gazdar; J D Minna; D Burch; A Marshall; S L Naylor
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

3.  Cytogenetic analyses of a murine carcinoma cell line and six metastatic derivatives with different degrees of radioresistability.

Authors:  R J Jamasbi; M Q Ye; T M Norvell
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-02       Impact factor: 2.416

4.  Localization of polymorphic DNA probes frequently deleted in lung carcinoma.

Authors:  D G Albertson; P D Sherrington; P H Rabbitts
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

Review 5.  Studying lung cancer in the laboratory: 3--Use of cell lines to investigate the biology of lung cancer.

Authors:  R J Fergusson; J F Smyth
Journal:  Thorax       Date:  1987-12       Impact factor: 9.139

Review 6.  Genetic changes in small cell lung carcinoma.

Authors:  Edurne Arriola; Israel Cañadas; Montse Arumí; Federico Rojo; Ana Rovira; Joan Albanell
Journal:  Clin Transl Oncol       Date:  2008-04       Impact factor: 3.405

7.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

Authors:  J W Harbour; S L Lai; J Whang-Peng; A F Gazdar; J D Minna; F J Kaye
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

8.  Establishing prostate cancer patient derived xenografts: lessons learned from older studies.

Authors:  Pamela J Russell; Peter Russell; Christina Rudduck; Brian W C Tse; Elizabeth D Williams; Derek Raghavan
Journal:  Prostate       Date:  2015-01-05       Impact factor: 4.104

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.